期刊文献+

老年白血病的特点及治疗进展 被引量:4

下载PDF
导出
摘要 白血病是一种克隆性的,起源于多能干细胞或早期的祖细胞水平的造血系统恶性肿瘤。此类细胞增殖失控、分化障碍、凋亡受阻,而停留在细胞发育中的不同阶段,丧失正常生理功能,并广泛地浸润骨髓、肝脏、脾脏、淋巴结等全身所有各脏器和组织,不仅正常造血功能受到抑制,且出现全身受累及的症状。全世界每年约有25万人患白血病,占肿瘤患者的2.5%。白血病的总体发病率呈稳定和缓慢增长,但是在老年人,近年来白血病的发生率有增高的趋势,尤其是急性髓细胞白血病,而且对常规化疗反应较差,这与老年患者的病理、生理特点以及其肿瘤的生物学特点有一定的关系。
作者 陈芳源
出处 《老年医学与保健》 CAS 2013年第1期7-11,共5页 Geriatrics & Health Care
基金 上海市卫生局重大课题(ZYSNXD-CC-ZDYJ001)
  • 相关文献

参考文献26

  • 1Dombret H, Raffoux E, Gardin C. Acute myeloid leukemiain the elderly [J]. Semin Oncol, 2008, 35 (4).:430438.
  • 2Pollyea DA, Kohrt HE, Medeiros BC. Acute myeloidleukaemiain the elderly: a review [J]. Br J Haematol, 2011,152 (5).: 524-542.
  • 3Farag SS, Archer KJ, Mrozek K, et al. Pretreatmentcytogenetics add to other prognostic factors predicting completeremission and long-term outcome in patients 60 years of age orolder with acute myeloid leukemia: results from Cancer andLeukemia Group B 8461 [S]. Blood, 2006, 108 (1).: 63-73.
  • 4Leith CP, KopeckyKJ, ChenIM, eta!. Frequency and clinicalsignificance of the expression of the multidrug resistance prote-ins MDRl/P-glycoprotein, MRP1, and LRP in acute myeloidleukemia: a Southwest Oncology Group Study [J]. Blood,1999,94 (3).: 1086-1099.
  • 5MenzinJ, LangK, Earle CC, etal. The outcomes and costsof acute myeloid leukemia among the elderly [J]. Arch InternMed, 2002, 162 (14).: 1597-1603.
  • 6Pautas C, Merabet F, Thomas X,et al. Randomized studyof intensi ed anthracycline doses for induction and recombinantinterleukin-2 for maintenance in patients with acute myeloid leu-kemia age 50 to 70 years: results of the ALFA-9801 study [J].J Clin Oncol, 2010,28 (5).: 808-814.
  • 7Schlenk RF, Frohling S, Hartmann F, etal. Phase III studyof all-trans retinoic acid in previously untreated patients 61 yearsor older with acute myeloid leukemia [J]. Leukemia, 2004,18 (11).: 1798-1803.
  • 8Lowenberg B, Ossenkoppele GJ, van Putten W, et al. High-dose daunorubicin in older patients with acute myeloid leukemia[J]. N Engl J Med, 2009, 361 (13).: 1235-1248.
  • 9Castaigne S, Pautas C, Terre C, etal. Effect of gemtuzumabozogamicin on survival of adult patients with de novo acute my-eloid leukaemia (ALFA-0701).:阻 randomised, open-label,phase 3 study [J]. Lancet, 2012,379 (9825).: 1508-1516.
  • 10Burnett AK, Milligan D, Prentice AG, etal. A comparisonof low-dose cytarabine and hydroxyurea with or without all-transretinoic acid for acute myeloid leukemia and high-risk myel-odysplastic syndrome in patients not considered fit for intensivetreatment [J]. Cancer, 2007, 109 (6).: 1114-1124.

同被引文献20

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部